Low-titer O whole blood in management of massive bleeding

The management of massively bleeding patients has undergone paradigm shift. With the evolution of bundle of care in form of damage control resuscitation, early blood-based resuscitation has emerged as one of the pillars of treatment; focused at preventing shock, coagulopathy, and thrombocytopenia. M...

Full description

Bibliographic Details
Main Author: Sangeeta Pahuja
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Global Journal of Transfusion Medicine
Subjects:
Online Access:http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2023;volume=8;issue=1;spage=4;epage=9;aulast=Pahuja
_version_ 1797775238862209024
author Sangeeta Pahuja
author_facet Sangeeta Pahuja
author_sort Sangeeta Pahuja
collection DOAJ
description The management of massively bleeding patients has undergone paradigm shift. With the evolution of bundle of care in form of damage control resuscitation, early blood-based resuscitation has emerged as one of the pillars of treatment; focused at preventing shock, coagulopathy, and thrombocytopenia. Military has always relied on low-titer O whole blood (LTOWB) to provide balanced hemostatic resuscitation for bleeding patients in combat casualties. Good results from military practice have led to questioning of practices followed in civilian bleeding trauma patients. With the realization that cold-stored platelets are functionally superior for immediate hemostasis, there is renewed interest in role of LTOWB in providing early hemostatic resuscitation to massively bleeding patients. Not only does LTOWB provide all the components but it also has an advantage of simplifying resuscitation logistics by providing all the components in one bag instead of three, in situations where delay of every minute leads to increased mortality. It can provide blood-based resuscitation in scenarios where it may not otherwise be possible. It can be used across all blood groups. This review explores the concerns regarding the use of LTOWB, historical perspective, advantages, and disadvantages. Several studies have shown that LTOWB is noninferior, as compared to components, and is a safe practice, without significant transfusion-related adverse events. The use of LTOWB in bleeding patients needs further studies to explore its efficacy and safety versus component therapy.
first_indexed 2024-03-12T22:32:52Z
format Article
id doaj.art-bf86d1cd917245aca3cb141b00750839
institution Directory Open Access Journal
issn 2468-8398
2455-8893
language English
last_indexed 2024-03-12T22:32:52Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Global Journal of Transfusion Medicine
spelling doaj.art-bf86d1cd917245aca3cb141b007508392023-07-21T14:39:06ZengWolters Kluwer Medknow PublicationsGlobal Journal of Transfusion Medicine2468-83982455-88932023-01-01814910.4103/gjtm.gjtm_38_22Low-titer O whole blood in management of massive bleedingSangeeta PahujaThe management of massively bleeding patients has undergone paradigm shift. With the evolution of bundle of care in form of damage control resuscitation, early blood-based resuscitation has emerged as one of the pillars of treatment; focused at preventing shock, coagulopathy, and thrombocytopenia. Military has always relied on low-titer O whole blood (LTOWB) to provide balanced hemostatic resuscitation for bleeding patients in combat casualties. Good results from military practice have led to questioning of practices followed in civilian bleeding trauma patients. With the realization that cold-stored platelets are functionally superior for immediate hemostasis, there is renewed interest in role of LTOWB in providing early hemostatic resuscitation to massively bleeding patients. Not only does LTOWB provide all the components but it also has an advantage of simplifying resuscitation logistics by providing all the components in one bag instead of three, in situations where delay of every minute leads to increased mortality. It can provide blood-based resuscitation in scenarios where it may not otherwise be possible. It can be used across all blood groups. This review explores the concerns regarding the use of LTOWB, historical perspective, advantages, and disadvantages. Several studies have shown that LTOWB is noninferior, as compared to components, and is a safe practice, without significant transfusion-related adverse events. The use of LTOWB in bleeding patients needs further studies to explore its efficacy and safety versus component therapy.http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2023;volume=8;issue=1;spage=4;epage=9;aulast=Pahujacomponentsdamage control resuscitationhemorrhagelow-titer o whole bloodmassive
spellingShingle Sangeeta Pahuja
Low-titer O whole blood in management of massive bleeding
Global Journal of Transfusion Medicine
components
damage control resuscitation
hemorrhage
low-titer o whole blood
massive
title Low-titer O whole blood in management of massive bleeding
title_full Low-titer O whole blood in management of massive bleeding
title_fullStr Low-titer O whole blood in management of massive bleeding
title_full_unstemmed Low-titer O whole blood in management of massive bleeding
title_short Low-titer O whole blood in management of massive bleeding
title_sort low titer o whole blood in management of massive bleeding
topic components
damage control resuscitation
hemorrhage
low-titer o whole blood
massive
url http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2023;volume=8;issue=1;spage=4;epage=9;aulast=Pahuja
work_keys_str_mv AT sangeetapahuja lowtiterowholebloodinmanagementofmassivebleeding